Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00022360
What this trial is testing

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT04289220
What this trial is testing

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Yan'an Affiliated Hospital of Kunming Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05632380
What this trial is testing

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT05710848
What this trial is testing

STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
SURGE Therapeutics 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Large-scale testing (Phase 3)UnknownNCT00565708
What this trial is testing

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers

Who this might be right for
Colorectal Cancer
National Cancer Centre, Singapore 1,587
Testing effectiveness (Phase 2)UnknownNCT01618474
What this trial is testing

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Who this might be right for
Stomach Cancer
Tianjin Medical University Cancer Institute and Hospital 100
Not applicableStudy completedNCT00470574
What this trial is testing

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 7
Not applicableEnded earlyNCT03404310
What this trial is testing

Zinc Sulfate for Human Papillomavirus (HPV)

Who this might be right for
Human Papilloma Virus
Corewell Health West 21
Not applicableNot Yet RecruitingNCT06966089
What this trial is testing

ExosomeDx in MRI-negative Men With High PSA

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 425
Testing effectiveness (Phase 2)WithdrawnNCT06182410
What this trial is testing

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Who this might be right for
Transplant-Associated Thrombotic MicroangiopathyNeuroblastomaHigh-risk Neuroblastoma+1 more
University of California, San Francisco
Testing effectiveness (Phase 2)UnknownNCT00373620
What this trial is testing

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Korean Gynecologic Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT02882282
What this trial is testing

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Who this might be right for
Oral Cavity CarcinomaOral Intraepithelial Neoplasia
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Temporarily pausedNCT04427306
What this trial is testing

Neoadjuvant T-VEC in High Risk Early Melanoma

Who this might be right for
Melanoma
University of California, Davis 6
Not applicableStudy completedNCT01520233
What this trial is testing

Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 100
Not applicableStudy completedNCT03856684
What this trial is testing

Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer

Who this might be right for
Cervical Cancer ScreeningCervical Cancer
University Hospital, Tours 10,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07109284
What this trial is testing

SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer

Who this might be right for
ER+HER2- Breast Cancer
West China Hospital 55
Early research (Phase 1)Active Not RecruitingNCT04147806
What this trial is testing

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT00559104
What this trial is testing

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 60
Not applicableStudy completedNCT00004565
What this trial is testing

Susceptibility to Breast Cancer

Who this might be right for
Breast CancerHealthy
National Cancer Institute (NCI) 737
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation